<?xml version="1.0" encoding="UTF-8"?>
<p>The specific symptomatology of coronavirus disease 2019 (COVID-19) has been challenging to define with the emergence of new symptoms with time. The most common clinical manifestations of COVID-19 include fever, cough, fatigue, dyspnea, sore throat, and headache. Multi-systemic symptoms like anosmia, diarrhea, and vomiting have also been reported [
 <xref rid="REF1" ref-type="bibr">1</xref>]. The most common patterns on chest CT imaging in these patients include ground-glass opacity (56.4%) and bilateral patchy shadowing (51.8%). Laboratory findings include lymphocytopenia in 83.2% of patients, thrombocytopenia in 36.2%, and leukopenia in 33.7% people [
 <xref rid="REF2" ref-type="bibr">2</xref>]. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a betacoronavirus belonging to the 
 <italic>Orthocoronavirinae</italic> subfamily, which also includes severe acute respiratory syndrome coronavirus (SARS-CoV) that caused the severe acute respiratory syndrome (SARS) outbreak in 2002 and the Middle East respiratory syndrome coronavirus (MERS CoV), which caused the MERS outbreak in 2012. The severity of the SARS-CoV-2 infection, when compared to that of SARS and MERS, shows the potential of these viruses to adapt and evolve according to the changing environment [
 <xref rid="REF3" ref-type="bibr">3</xref>].
</p>
